Drug recall D-0087-2023
Product
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lots: 01422002A1, Expiry: 12/2023; 01421078A3, Expiry: 09/2023
Recall details
- Recalling firm
- Aurolife Pharma, LLC, Dayton, NJ
- Quantity
- 7344 bottles
- Distribution
- Nationwide in the USA and Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 16, 2022
Related products
- Glycopyrrolate – drug information
- NDC 13107-015 Glycopyrrolate · Glycopyrrolate 2 mg/1 · Aurolife Pharma LLC
- NDC 13107-014 Glycopyrrolate · Glycopyrrolate 1 mg/1 · Aurolife Pharma LLC